7MW4911 for Gastrointestinal Cancer
What You Need to Know Before You Apply
What is the purpose of this trial?
This is the first-in-human study of 7MW4911 in US patients, to investigate its prelimary safety and efficacy in patients with gastrointestinal cancers.
Are You a Good Fit for This Trial?
Adults over 18 with advanced or metastatic gastrointestinal cancer that worsened after standard treatment can join this trial. They should be relatively healthy (ECOG 0-1), expected to live at least 3 months, have a measurable tumor, and provide tissue samples. Good blood, liver, and kidney function are needed, along with following birth control rules.Inclusion Criteria
What Are the Treatments Tested in This Trial?
Interventions
- 7MW4911
Trial Overview
The study is testing the safety and effectiveness of a new drug called 7MW4911 for patients in the US with gastrointestinal cancers. It's the first time humans will receive this drug.
How Is the Trial Designed?
1
Treatment groups
Experimental Treatment
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mabwell (Shanghai) Bioscience Co., Ltd.
Lead Sponsor
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.